NASDAQ · XTLB
XTL Biopharmaceuticals Ltd.
Healthcare · Biotechnology
$2.40
Up+$0.01 (+0.42%)
Updated Sep 18, 2026, 4:12 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.63M
- P/E ratio
- -4.03
- Dividend yield
- 0.00%
- 52-week range
- $2.01 – $10.28
- Volume
- 3K
- Avg. volume
- 813.17K
Price performance
XTLB price history
1M range · 19 trading sessions · Daily adjusted prices
XTLB closed at $2.40 after 19 trading sessions, down 13.10% for the selected period.
- Last close
- $2.40
- Period change
- -13.10%
- Period low
- $2.32
- Period high
- $2.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $2.40 | $2.40 | $2.35 | $2.40 | 3K |
| Sep 16, 2026 | $2.4788 | $2.49 | $2.38 | $2.39 | 1.73K |
| Sep 15, 2026 | $2.40 | $2.4999 | $2.28 | $2.4999 | 5.34K |
| Sep 14, 2026 | $2.47 | $2.51 | $2.40 | $2.43 | 2.22K |
| Sep 11, 2026 | $2.475 | $2.559 | $2.465 | $2.559 | 1.6K |
| Sep 9, 2026 | $2.436 | $2.5602 | $2.40 | $2.52 | 6.26K |
| Sep 8, 2026 | $2.5297 | $2.53 | $2.5297 | $2.53 | 666.55 |
| Sep 4, 2026 | $2.4322 | $2.53 | $2.4322 | $2.53 | 1.83K |
| Sep 3, 2026 | $2.60 | $2.60 | $2.46 | $2.50 | 2.71K |
| Sep 2, 2026 | $2.35 | $2.69 | $2.32 | $2.66 | 33.32K |
| Sep 1, 2026 | $2.44 | $2.47 | $2.32 | $2.32 | 4.02K |
| Aug 31, 2026 | $2.51 | $2.575 | $2.48 | $2.49 | 7.63K |
| Aug 28, 2026 | $2.51 | $2.70 | $2.47 | $2.47 | 8.24K |
| Aug 27, 2026 | $2.4678 | $2.58 | $2.4678 | $2.58 | 2.66K |
| Aug 26, 2026 | $2.63 | $2.63 | $2.3496 | $2.58 | 2.6K |
| Aug 25, 2026 | $2.64 | $2.64 | $2.58 | $2.60 | 4.08K |
| Aug 24, 2026 | $2.66 | $2.66 | $2.6252 | $2.6252 | 1.16K |
| Aug 21, 2026 | $2.78 | $2.78 | $2.78 | $2.78 | 520.05 |
| Aug 20, 2026 | $2.83 | $3.05 | $2.7619 | $2.7619 | 4.42K |
Latest XTLB news
The latest Smart Investors Daily articles mentioning XTLB.
Stock researchCompany · Forecast
Loading stock research…
